相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Image analysis as an adjunct to manual HER-2 immunohistochemical review: a diagnostic tool to standardize interpretation
Lynne Dobson et al.
HISTOPATHOLOGY (2010)
HER-2 amplification is highly homogenous in gastric cancer
Michael Bilous et al.
HUMAN PATHOLOGY (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing
Josef Rueschoff et al.
VIRCHOWS ARCHIV (2010)
Digestive biopsy indicators during fibroscopy or the detection of oeso-gastro-duodenal neoplasia
D. Heresbach et al.
ACTA ENDOSCOPICA (2009)
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
C. Gravalos et al.
ANNALS OF ONCOLOGY (2008)
Assessment of a HER2 scoring system for gastric cancer:: results from a validation study
M. Hofmann et al.
HISTOPATHOLOGY (2008)
Standardization of HER2 testing:: results of an international proficiency-testing ring study
Mitch Dowsett et al.
MODERN PATHOLOGY (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
HER-2/neu amplification is an independent prognostic factor in gastric cancer
Dong Il Park et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world
Farin Kamangar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gastric cancer screening and subsequent risk of gastric cancer: A large-scale population-based cohort study, with a 13-year follow-up in Japan
KJ Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Epidemiology of gastric cancer in Japan
M Inoue et al.
POSTGRADUATE MEDICAL JOURNAL (2005)
Survival after gastric adenocarcinoma resection: Eighteen-year experience at a single institution
SC Cunningham et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2005)
Amplification of HER-2 in gastric carcinoma:: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab
M Tanner et al.
ANNALS OF ONCOLOGY (2005)
Current perspectives on HER2 testing:: A review of national testing guidelines
M Bilous et al.
MODERN PATHOLOGY (2003)
Status of c-erbB-2 in gastric adenocarcinoma:: A comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay
T Takehana et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Overexpression of HER2/neu in solid tumours: an immunohistochemical survey
HKW Koeppen et al.
HISTOPATHOLOGY (2001)
分享论文
